Collections

Filters ​

  • Focus |

    A series of articles that focuses on the massively parallel sequencing technology that are making progress in the quest for a $1000 human genome sequence.

  • Focus |

    This issue provides several articles focusing on antiviral therapy. Additional material, brought together in a joint focus with Nature Reviews Drug Discoverysupported by our principal sponsor Pfizer and our supporting sponsor Gilead.

  • Focus |

    A collection of articles from Nature Biotechnology, brought together in a joint focus with Nature Reviews Drug Discovery, on the science and business of antibacterial discovery and development.

  • Collection |

    This supplement collects together reprints of papers from Nature Biotechnology reporting the first formal results of a consortium of over 150 regulatory, industrial and academic scientists that set out to conduct a cross-platform analysis of DNA microarray expression data obtained from two, commercially available RNA samples.

  • Focus |

    The first formal results of a consortium of over 150 regulatory, industrial and academic scientists that set out to conduct a cross-platform analysis of DNA microarray expression data obtained from two, commercially available RNA samples.

  • Focus |

    A series of articles that focuses on the scientific, business, regulatory, intellectual property, technology transfer and logistical challenges of accelerating integration of molecular diagnostics into clinical practice and therapy selection.

  • Focus |

    A focus celebrating 10 years of serving the biotech community.

  • Focus |

    A focus examining the scientific, legal, regulatory, and commercial context of current cell research for regenerative medicine.

  • Focus |

    As more biotech products receive regulatory approval and the first protein blockbusters come off patent and face generic competition, this focus discusses the challenges for companies manufacturing recombinant proteins.

  • Focus |

    Nature Biotechnology,Nature MedicineandNature Cell Biologypresent a joint supplement on monoclonal antibodies and therapies. The focus is on basic, technological and clinical aspects of their use, across fields that range from transplantation tolerance to colon cancer.